Erbitux shortage — IE supply status & alternatives

Erbitux

—

🇦🇺 AUST R 132393 · Merck Serono Australia Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇮🇪 IE

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	Erbitux
Therapeutic category	Auto-created by FDA Drug Enforcement — Full Recall Database scraper
Controlled substance	No
Marketing-authorisation holders	Merck Serono Australia Pty Ltd, ImClone LLC, Merck Europe B.V., IMCLONE, LLC

Registrations on file	5

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇮🇪

Ireland

HPRA · 2d ago

Medium

Recalls official enforcement reports

🇺🇸

Erbitux

Infusion Options, Inc. · June 2019

Class IIdetails ↗

Verified timeline regulator events

🇮🇪 6 July 2026

medium reported

Sources official regulators

🇮🇪

HPRA

verified 2d ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders5 registrations · 4 MA holders

Product	Strength	Form	Market	MA holder	Status
ERBITUX cetuximab	100mg	—	🇦🇺 AU	Merck Serono Australia Pty Ltd	Active
ERBITUX cetuximab	500mg	—	🇦🇺 AU	Merck Serono Australia Pty Ltd	Active
ERBITUX	2mg/mL	solution	🇺🇸 US	ImClone LLC	Active
Erbitux	—	—	🌐 EU	Merck Europe B.V.	Active
ERBITUX	—	solution	🇨🇦 CA	IMCLONE, LLC	Active

Mederti Drug Report

Generated 3 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.